Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction.

Cardiac rupture remains a fatal complication of acute myocardial infarction (MI) with its mechanism partially understood. We hypothesized that damage to the collagen matrix of infarcted myocardium is the central mechanism of rupture and therefore responsible for the difference in the incidence of rupture between genders. We examined left ventricular (LV) remodeling during the acute phase post-MI in 129sv mice. Following induction of MI, we monitored rupture events and assessed the extent of LV remodeling by echocardiography. Muscle tensile strength, content of insoluble and soluble collagen, expression and activity of matrix metalloproteinases (MMPs) and density of inflammatory cells were determined in the infarcted and non-infarcted myocardium. We then tested the effects of MMP inhibition on rupture. Compared to female mice, males with MI displayed greater extent of LV remodeling, reduced muscle tensile strength, loss of insoluble collagen, local inflammatory response and MMP-9 activation, changes associated with a 3 times higher incidence of rupture than in females. MMP-9 expression by circulating blood mononuclear cells was also increased in male mice with acute MI. Treatment of male mice with an MMP inhibitor reduced MMP activity and halved rupture incidence. Our findings demonstrate that the differences in the severity of inflammation, MMP activation and damage to collagen matrix account for gender difference in cardiac rupture. Our study illustrates the breakdown of fibril collagen as a central mechanism of cardiac rupture.

[1]  D R Boughner,et al.  Role of Collagen in Acute Myocardial Infarct Expansion , 1991, Circulation.

[2]  A. Takeshita,et al.  Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. , 2003, American journal of physiology. Heart and circulatory physiology.

[3]  P. Libby,et al.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.

[4]  J. Skurnick,et al.  Cardiac Rupture in Acute Myocardial Infarction: A Reassessment , 2002, The American journal of forensic medicine and pathology.

[5]  Leslie L. Clark,et al.  Specific Temporal Profile of Matrix Metalloproteinase Release Occurs in Patients After Myocardial Infarction: Relation to Left Ventricular Remodeling , 2006, Circulation.

[6]  Xiaojun Du,et al.  Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats , 2005, Hypertension.

[7]  M. Cavasin,et al.  Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. , 2006, American journal of physiology. Heart and circulatory physiology.

[8]  M. Cavasin,et al.  Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. , 2004, Life sciences.

[9]  E. Antman,et al.  Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. , 1999, Journal of the American College of Cardiology.

[10]  D. Stajer,et al.  Neutrophils in human myocardial infarction with rupture of the free wall. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  K. Nakao,et al.  Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction , 2004, Circulation.

[12]  A. Maggi,et al.  Regulation of the lipopolysaccharide signal transduction pathway by 17β-estradiol in macrophage cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  P. Libby,et al.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.

[14]  A. Dart,et al.  Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. , 2005, Cardiovascular research.

[15]  R. O'rourke,et al.  Comparative Accuracy of Apical Biplane Cross‐sectional Echocardiography and Gated Equilibrium Radionuclide Angiography for Estimating Left Ventricular Size and Performance , 1981, Circulation.

[16]  I. Godsland,et al.  17β-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells , 1998 .

[17]  S. Sankey,et al.  Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. , 2003, American journal of physiology. Heart and circulatory physiology.

[18]  Merry Lindsey,et al.  Matrix-Dependent Mechanism of Neutrophil-Mediated Release and Activation of Matrix Metalloproteinase 9 in Myocardial Ischemia/Reperfusion , 2001, Circulation.

[19]  J. Hayakawa,et al.  Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor &agr; , 2006, Menopause.

[20]  E. Antman,et al.  Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. , 1989, American heart journal.

[21]  R. Visse,et al.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .

[22]  David Handelsman,et al.  Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. , 2004, Endocrinology.

[23]  Y. Okada,et al.  Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. , 2005, The Journal of clinical investigation.

[24]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[25]  R. M. Rubison,et al.  A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. , 1996, Journal of the American College of Cardiology.

[26]  M. Mori,et al.  Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. , 2004, Life sciences.

[27]  M. Radomski,et al.  Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. , 2000, Circulation.

[28]  G. Jerums,et al.  The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  A. Dart,et al.  Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. , 2000, Cardiovascular research.

[30]  W. Roberts,et al.  Out-of-hospital sudden death from left ventricular free wall rupture during acute myocardial infarction as the first and only manifestation of atherosclerotic coronary artery disease. , 1994, The American journal of cardiology.

[31]  A. Dart,et al.  Lower Risk of Postinfarct Rupture in Mouse Heart Overexpressing &bgr;2-Adrenergic Receptors: Importance of Collagen Content , 2002, Journal of cardiovascular pharmacology.

[32]  Richard T. Lee,et al.  Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.